Skip to main content
Erschienen in: Inflammation 2/2015

01.04.2015

Vitamin D Improves Cognitive Function and Modulates Th17/Treg Cell Balance After Hepatectomy in Mice

verfasst von: Ayong Tian, Hong Ma, Xuezhao Cao, Rongwei Zhang, Xiaolong Wang, Binyang Wu

Erschienen in: Inflammation | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

It is known that surgery-induced tissue damage activates the peripheral immune system resulting in the release of inflammatory mediators and cognitive impairment in aged mice. Vitamin D has been shown to have immunomodulatory function, but the molecular basis for it has not been well understood. In this study, we mainly investigated the efficacy and mechanism of vitamin D against postoperative cognitive dysfunction (POCD). The treatment of C57BL mice with vitamin D significantly preserves postoperative cognitive function, markedly inhibits surgery-induced interleukin (IL)-17, IL-6, transforming growth factor beta (TGF-β), and retinoic acid-related orphan receptor (RORγt) production, and obviously induces IL-10 and forkhead box p3 (Foxp3) expression. These findings indicate that vitamin D amelioration of POCD is, to a large extent, due to inhibit inflammatory CD4_T cell lineage, T helper 17 (Th17) cells, accompanied with expansion in regulatory T cells (Treg cells), a subset of CD4_T cells that are important in inhibiting inflammation. Our results suggest that Th17 and Treg cell imbalance may play a role in the development of POCD. Vitamin D is useful in the control of inflammatory diseases.
Literatur
1.
Zurück zum Zitat Rudolph, J.L., K.A. Schreiber, D.J. Culley, R.E. Mcglinchey, G. Crosby, S. Levitsky, and E.R. Marcantonio. 2010. Measurement of postoperative cognitive dysfunction after cardiac surgery: a systematic review. Acta Anaesthesiologica Scandinavica 54: 663–677.PubMedCentralPubMedCrossRef Rudolph, J.L., K.A. Schreiber, D.J. Culley, R.E. Mcglinchey, G. Crosby, S. Levitsky, and E.R. Marcantonio. 2010. Measurement of postoperative cognitive dysfunction after cardiac surgery: a systematic review. Acta Anaesthesiologica Scandinavica 54: 663–677.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Rosczyk, H.A., N.L. Sparkman, and R.W. Johnson. 2008. Neuroinflammation and cognitive function in aged mice following minor surgery. Experimental Gerontology 43: 840–846.PubMedCentralPubMedCrossRef Rosczyk, H.A., N.L. Sparkman, and R.W. Johnson. 2008. Neuroinflammation and cognitive function in aged mice following minor surgery. Experimental Gerontology 43: 840–846.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Abildstrom, H., L.S. Rasmussen, P. Rentowl, C.D. Hanning, H. Rasmussen, P.A. Kristensen, P.A. Kristensen, and J.T. Moller. 2000. Cognitive dysfunction 1-2 years after noncardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiologica Scandinavica 44: 1246–1251.PubMedCrossRef Abildstrom, H., L.S. Rasmussen, P. Rentowl, C.D. Hanning, H. Rasmussen, P.A. Kristensen, P.A. Kristensen, and J.T. Moller. 2000. Cognitive dysfunction 1-2 years after noncardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiologica Scandinavica 44: 1246–1251.PubMedCrossRef
4.
Zurück zum Zitat Kadoi, Y., and F. Goto. 2006. Factors associated with postoperative cognitive dysfunction in patients undergoing cardiac surgery. Surgery Today 36: 1053–1057.PubMedCrossRef Kadoi, Y., and F. Goto. 2006. Factors associated with postoperative cognitive dysfunction in patients undergoing cardiac surgery. Surgery Today 36: 1053–1057.PubMedCrossRef
5.
Zurück zum Zitat Gao, L., R. Taha, D. Gauvin, L.B. Othmen, Y. Wang, and G. Blaise. 2005. Postoperative cognitive dysfunction after cardiac surgery. Chest 128: 3664–3670.PubMedCrossRef Gao, L., R. Taha, D. Gauvin, L.B. Othmen, Y. Wang, and G. Blaise. 2005. Postoperative cognitive dysfunction after cardiac surgery. Chest 128: 3664–3670.PubMedCrossRef
6.
Zurück zum Zitat Sparkman, N.L., and R.W. Johnson. 2008. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 15: 323–330.PubMedCentralPubMedCrossRef Sparkman, N.L., and R.W. Johnson. 2008. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 15: 323–330.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Cao, X.Z., H. Ma, J.K. Wang, F. Liu, B.Y. Wu, A.Y. Tian, L.L. Wang, and W.F. Tan. 2010. Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats. Progress in Neuropsychopharmacology and Biological Psychiatry 34: 1426–1432.CrossRef Cao, X.Z., H. Ma, J.K. Wang, F. Liu, B.Y. Wu, A.Y. Tian, L.L. Wang, and W.F. Tan. 2010. Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats. Progress in Neuropsychopharmacology and Biological Psychiatry 34: 1426–1432.CrossRef
8.
Zurück zum Zitat Wan, Y., J. Xu, D. Ma, Y. Zeng, M. Cibelli, and M. Maze. 2007. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 106: 436–443.PubMedCrossRef Wan, Y., J. Xu, D. Ma, Y. Zeng, M. Cibelli, and M. Maze. 2007. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 106: 436–443.PubMedCrossRef
9.
Zurück zum Zitat Quan, N., and W.A. Banks. 2007. Brain-immune communication pathways. Brain, Behavior, and Immunity 21: 727–735.PubMedCrossRef Quan, N., and W.A. Banks. 2007. Brain-immune communication pathways. Brain, Behavior, and Immunity 21: 727–735.PubMedCrossRef
10.
Zurück zum Zitat Watkins, L.R., L.E. Goehler, J.K. Relton, N. Tartaglia, L. Silbert, D. Martin, and S.F. Maier. 1995. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neuroscience Letters 183: 27–31.PubMedCrossRef Watkins, L.R., L.E. Goehler, J.K. Relton, N. Tartaglia, L. Silbert, D. Martin, and S.F. Maier. 1995. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neuroscience Letters 183: 27–31.PubMedCrossRef
11.
Zurück zum Zitat Chabaud, M., F. Fossiez, J.L. Taupin, and P. Miossec. 1998. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. The Journal of Immunology 161: 409–414.PubMed Chabaud, M., F. Fossiez, J.L. Taupin, and P. Miossec. 1998. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. The Journal of Immunology 161: 409–414.PubMed
12.
Zurück zum Zitat Garrett-Sinha, L.A., S. John, and S.L. Gaffen. 2008. IL-17 and the Th17 lineage in systemic lupus erythematosus. Current Opinion in Rheumatology 20: 519–525.PubMedCrossRef Garrett-Sinha, L.A., S. John, and S.L. Gaffen. 2008. IL-17 and the Th17 lineage in systemic lupus erythematosus. Current Opinion in Rheumatology 20: 519–525.PubMedCrossRef
13.
Zurück zum Zitat Hsu, H.C., P.A. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A.L. Stanus, T.L. Le, R.G. Lorenz, H. Xu, J.K. Kolls, R.H. Carter, D.D. Chaplin, R.W. Williams, and J.D. Mountz. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nature Immunology 9: 166–175.PubMedCrossRef Hsu, H.C., P.A. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A.L. Stanus, T.L. Le, R.G. Lorenz, H. Xu, J.K. Kolls, R.H. Carter, D.D. Chaplin, R.W. Williams, and J.D. Mountz. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nature Immunology 9: 166–175.PubMedCrossRef
14.
Zurück zum Zitat Matusevicius, D., P. Kivisäkk, B. He, N. Kostulas, V. Ozenci, S. Fredrikson, and H. Link. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Multiple Sclerosis 5: 101–104.PubMedCrossRef Matusevicius, D., P. Kivisäkk, B. He, N. Kostulas, V. Ozenci, S. Fredrikson, and H. Link. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Multiple Sclerosis 5: 101–104.PubMedCrossRef
15.
Zurück zum Zitat Dong, C. 2008. Th17 cells in development: an updated view of their molecular identity and genetic programming. Nature Reviews Immunology 8: 337–348.PubMedCrossRef Dong, C. 2008. Th17 cells in development: an updated view of their molecular identity and genetic programming. Nature Reviews Immunology 8: 337–348.PubMedCrossRef
16.
Zurück zum Zitat Weaver, C.T., R.D. Hatton, P.R. Mangan, and L.E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annual Review of Immunology 25: 821–852.PubMedCrossRef Weaver, C.T., R.D. Hatton, P.R. Mangan, and L.E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annual Review of Immunology 25: 821–852.PubMedCrossRef
17.
18.
Zurück zum Zitat Ivanov, I.I., B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J.D.J. Lafaille, and D.R.L. Cua. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121–1133.PubMedCrossRef Ivanov, I.I., B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J.D.J. Lafaille, and D.R.L. Cua. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121–1133.PubMedCrossRef
19.
Zurück zum Zitat Chung, Y., S.H. Chang, G.J. Martinez, X.O. Yang, R. Nurieva, H.S. Kang, L. Ma, S.S. Watowich, A.M. Jetten, Q. Tian, and C. Dong. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576–587.PubMedCentralPubMedCrossRef Chung, Y., S.H. Chang, G.J. Martinez, X.O. Yang, R. Nurieva, H.S. Kang, L. Ma, S.S. Watowich, A.M. Jetten, Q. Tian, and C. Dong. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576–587.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua. 2005. IL23 drives a pathegenic T cell population that induces autoimmune inflammation. Journal of Experimental Medicine 201: 233–240.PubMedCentralPubMedCrossRef Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua. 2005. IL23 drives a pathegenic T cell population that induces autoimmune inflammation. Journal of Experimental Medicine 201: 233–240.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Holick, M.F. 1996. Vitamin D and bone health. Journal of Nutrition 126: 1159S–1164S.PubMed Holick, M.F. 1996. Vitamin D and bone health. Journal of Nutrition 126: 1159S–1164S.PubMed
22.
Zurück zum Zitat Mora, J.R., M. Iwata, and U.H. Von Andrian. 2008. Vitamin effects on the immune system: vitamins A and D take centre stage. Nature Reviews Immunology 8: 685–698.PubMedCentralPubMedCrossRef Mora, J.R., M. Iwata, and U.H. Von Andrian. 2008. Vitamin effects on the immune system: vitamins A and D take centre stage. Nature Reviews Immunology 8: 685–698.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Jeffery, L.E., F. Burke, M. Mura, F. Burke, M. Mura, Y. Zheng, L.S.K. Walker, D.A. Lammas, K. Raza, and D.M. Sansom. 2009. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. The Journal of Immunology 183: 5458–5467.PubMedCentralPubMedCrossRef Jeffery, L.E., F. Burke, M. Mura, F. Burke, M. Mura, Y. Zheng, L.S.K. Walker, D.A. Lammas, K. Raza, and D.M. Sansom. 2009. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. The Journal of Immunology 183: 5458–5467.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Staeva-Vieira, T.P., and L.P. Freedman. 2002. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. The Journal of Immunology 168: 1181–1189.PubMedCrossRef Staeva-Vieira, T.P., and L.P. Freedman. 2002. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. The Journal of Immunology 168: 1181–1189.PubMedCrossRef
25.
Zurück zum Zitat Mahon, B.D., A. Wittke, V. Weaver, and M.T. CAntoma. 2003. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. Journal of Cellular Biochemistry 89: 22–932.CrossRef Mahon, B.D., A. Wittke, V. Weaver, and M.T. CAntoma. 2003. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. Journal of Cellular Biochemistry 89: 22–932.CrossRef
26.
Zurück zum Zitat Sigmundsdottir, H., J. Pan, G.F. Debes, C. Alt, A. Habtezion, D. Soler, and E.C. Butcher. 2007. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nature Immunology 8: 285–293.PubMedCrossRef Sigmundsdottir, H., J. Pan, G.F. Debes, C. Alt, A. Habtezion, D. Soler, and E.C. Butcher. 2007. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nature Immunology 8: 285–293.PubMedCrossRef
27.
Zurück zum Zitat Gorman, S., L.A. Kuritzky, M.A. Judge, K.M. Dixon, J.P. Mcglade, R.S. Mason, J.J. Finlay-Jones, and P.H. Hart. 2007. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4 + CD25+ cells in the draining lymph nodes. The Journal of Immunology 179: 6273–6283.PubMedCrossRef Gorman, S., L.A. Kuritzky, M.A. Judge, K.M. Dixon, J.P. Mcglade, R.S. Mason, J.J. Finlay-Jones, and P.H. Hart. 2007. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4 + CD25+ cells in the draining lymph nodes. The Journal of Immunology 179: 6273–6283.PubMedCrossRef
28.
Zurück zum Zitat Pedersen, L.B., F.E. Nashold, K.M. Spach, and C.E. Hayes. 2007. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. Journal of Neuroscience Research 85: 2480–2490.PubMedCrossRef Pedersen, L.B., F.E. Nashold, K.M. Spach, and C.E. Hayes. 2007. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. Journal of Neuroscience Research 85: 2480–2490.PubMedCrossRef
29.
Zurück zum Zitat Penna, G., S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, F. Sanvito, C. Doglioni, and L. Adorini. 2006. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. Journal of Immunology 177: 8504–8511.CrossRef Penna, G., S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, F. Sanvito, C. Doglioni, and L. Adorini. 2006. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. Journal of Immunology 177: 8504–8511.CrossRef
30.
Zurück zum Zitat Tang, J., R. Zhou, D. Luger, W. Zhu, P.B. Silver, R.S. Grajewski, S.B. Su, C.C. Chan, L. Adorini, and R.R. Caspi. 2009. Calcitriol suppresses anti-retinal autoimmunity through inhibitory effects on the Th17 effector response. The Journal of Immunology 182: 4624–4632.PubMedCentralPubMedCrossRef Tang, J., R. Zhou, D. Luger, W. Zhu, P.B. Silver, R.S. Grajewski, S.B. Su, C.C. Chan, L. Adorini, and R.R. Caspi. 2009. Calcitriol suppresses anti-retinal autoimmunity through inhibitory effects on the Th17 effector response. The Journal of Immunology 182: 4624–4632.PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Vorhees, C.V., and M.T. Williams. 2006. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature Protocols 1: 848–858.PubMedCentralPubMedCrossRef Vorhees, C.V., and M.T. Williams. 2006. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature Protocols 1: 848–858.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat O’Garra, A., and P. Vieira. 2003. Twenty-first century Foxp3. Nature Immunology 4: 304–306.PubMedCrossRef O’Garra, A., and P. Vieira. 2003. Twenty-first century Foxp3. Nature Immunology 4: 304–306.PubMedCrossRef
33.
Zurück zum Zitat Cibelli, M. 2010. A.R. Fidalgo, N. Terrando, D. Ma, C. Monaco, M. Feldmann, M. Takata, I.J. Lever, J. Nanchahal, M.S. Fanselow, M. Maze. 2010. Role of interleukin-1beta in postoperative cognitive dysfunction. Annals of Neurology 68: 360–368.PubMedCrossRef Cibelli, M. 2010. A.R. Fidalgo, N. Terrando, D. Ma, C. Monaco, M. Feldmann, M. Takata, I.J. Lever, J. Nanchahal, M.S. Fanselow, M. Maze. 2010. Role of interleukin-1beta in postoperative cognitive dysfunction. Annals of Neurology 68: 360–368.PubMedCrossRef
34.
Zurück zum Zitat Terrando, N., C. Monaco, D. Ma, B.M. Foxwell, M. Feldmann, and M. Maze. 2010. Tumor necrosis factor- alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proceedings of the National Academy of Sciences of the United States of America 107: 20518–20522.PubMedCentralPubMedCrossRef Terrando, N., C. Monaco, D. Ma, B.M. Foxwell, M. Feldmann, and M. Maze. 2010. Tumor necrosis factor- alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proceedings of the National Academy of Sciences of the United States of America 107: 20518–20522.PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Munger, K.L., S.M. Zhang, E. O’Reilly, M.A. Hernanma, M.J. Olek, W.C. Willett, and A. Ascherio. 2004. Vitamin D intake and incidence of multiple sclerosis. Neurology 62: 60–65.PubMedCrossRef Munger, K.L., S.M. Zhang, E. O’Reilly, M.A. Hernanma, M.J. Olek, W.C. Willett, and A. Ascherio. 2004. Vitamin D intake and incidence of multiple sclerosis. Neurology 62: 60–65.PubMedCrossRef
36.
37.
Zurück zum Zitat Simon, K.C., K.L. Munger, Y. Xing, and A. Ascherio. 2010. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis 16: 133–138.PubMedCentralPubMedCrossRef Simon, K.C., K.L. Munger, Y. Xing, and A. Ascherio. 2010. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis 16: 133–138.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Cantorna, M.T., C.E. Hayes, and H.F. DeLuca. 1996. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 93: 7861–7864.PubMedCentralPubMedCrossRef Cantorna, M.T., C.E. Hayes, and H.F. DeLuca. 1996. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 93: 7861–7864.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Lemire, J.M., and D.C. Archer. 1991. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. Journal of Clinical Investigation 87: 1103–1107.PubMedCentralPubMedCrossRef Lemire, J.M., and D.C. Archer. 1991. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. Journal of Clinical Investigation 87: 1103–1107.PubMedCentralPubMedCrossRef
40.
Zurück zum Zitat Chang, J.H., H.R. Cha, D.S. Lee, K.Y. Seo, and M.N. Kweon. 2010. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of TH17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 5: e12925.PubMedCentralPubMedCrossRef Chang, J.H., H.R. Cha, D.S. Lee, K.Y. Seo, and M.N. Kweon. 2010. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of TH17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 5: e12925.PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Correale, J., M.C. Ysrraelit, and M.I. Gaitan. 2009. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132: 1146–1160.PubMedCrossRef Correale, J., M.C. Ysrraelit, and M.I. Gaitan. 2009. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132: 1146–1160.PubMedCrossRef
42.
Zurück zum Zitat Colin, E.M., P.S. Asmawidjaja, J.P. van Hamburg, A.M. Mus, M. Van Driel, J.M. Hazes, J.P. van Leeuwen, and E. Lubberts. 2010. 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis and Rheumatism 62: 132–142.PubMedCrossRef Colin, E.M., P.S. Asmawidjaja, J.P. van Hamburg, A.M. Mus, M. Van Driel, J.M. Hazes, J.P. van Leeuwen, and E. Lubberts. 2010. 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis and Rheumatism 62: 132–142.PubMedCrossRef
43.
Zurück zum Zitat Daniel, C., N.A. Sartory, N. Zahn, H.H. Radeke, and J.M. Stein. 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Journal of Pharmacology and Experimental Therapeutics 324: 23–33.PubMedCrossRef Daniel, C., N.A. Sartory, N. Zahn, H.H. Radeke, and J.M. Stein. 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Journal of Pharmacology and Experimental Therapeutics 324: 23–33.PubMedCrossRef
44.
Zurück zum Zitat Yang, L., D.E. Anderson, C. Baecher-Allan, W.D. Hastings, E. Bettelli, M. Oukka, V.K. Kuchroo, and D.A. Hafler. 2008. IL-21 and TGFbeta are required for differentiation of human T(H)17 cells. Nature 454: 350–352.PubMedCentralPubMedCrossRef Yang, L., D.E. Anderson, C. Baecher-Allan, W.D. Hastings, E. Bettelli, M. Oukka, V.K. Kuchroo, and D.A. Hafler. 2008. IL-21 and TGFbeta are required for differentiation of human T(H)17 cells. Nature 454: 350–352.PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Nurieva, R., X.O. Yang, G. Martinez, Y. Zhang, A.D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S.S. Watowich, A.M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480–483.PubMedCrossRef Nurieva, R., X.O. Yang, G. Martinez, Y. Zhang, A.D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S.S. Watowich, A.M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480–483.PubMedCrossRef
46.
Zurück zum Zitat Mangan, P.R., L.E. Harrington, D.B. O’Quinn, W.S. Helms, D.C. Bullard, C.O. Elson, R.D. Hatton, S.M. Wahl, T.R. Schoeb, and C.T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231–234.PubMedCrossRef Mangan, P.R., L.E. Harrington, D.B. O’Quinn, W.S. Helms, D.C. Bullard, C.O. Elson, R.D. Hatton, S.M. Wahl, T.R. Schoeb, and C.T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231–234.PubMedCrossRef
47.
Zurück zum Zitat Rachitskaya, A.V., A.M. Hansen, R. Horai, Z. Li, R. Villasmil, D. Luger, R.B. Nussenblatt, and R.R. Caspi. 2008. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. The Journal of Immunology 180: 5167–5171.PubMedCentralPubMedCrossRef Rachitskaya, A.V., A.M. Hansen, R. Horai, Z. Li, R. Villasmil, D. Luger, R.B. Nussenblatt, and R.R. Caspi. 2008. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. The Journal of Immunology 180: 5167–5171.PubMedCentralPubMedCrossRef
48.
Zurück zum Zitat Zhou, L., I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D.E. Levy, W.J. Leonard, and D.R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 8: 967–974.PubMedCrossRef Zhou, L., I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D.E. Levy, W.J. Leonard, and D.R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 8: 967–974.PubMedCrossRef
49.
Zurück zum Zitat Wei, L., A. Laurence, K.M. Elias, and J.J. O’Shea. 2007. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. Journal of Biological Chemistry 282: 34605–346010.PubMedCentralPubMedCrossRef Wei, L., A. Laurence, K.M. Elias, and J.J. O’Shea. 2007. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. Journal of Biological Chemistry 282: 34605–346010.PubMedCentralPubMedCrossRef
50.
Zurück zum Zitat Ichiyama, K., H. Yoshida, Y. Wakabayashi, T. Chinen, K. Saeki, M. Nakaya, G. Takaesu, S. Hori, A. Yoshimura, and T. Kobayashi. 2008. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. Journal of Biological Chemistry 283: 17003–17008.PubMedCrossRef Ichiyama, K., H. Yoshida, Y. Wakabayashi, T. Chinen, K. Saeki, M. Nakaya, G. Takaesu, S. Hori, A. Yoshimura, and T. Kobayashi. 2008. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. Journal of Biological Chemistry 283: 17003–17008.PubMedCrossRef
51.
Zurück zum Zitat Manel, N., D. Unutmaz, and D.R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nature Immunology 9: 641–649.PubMedCentralPubMedCrossRef Manel, N., D. Unutmaz, and D.R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nature Immunology 9: 641–649.PubMedCentralPubMedCrossRef
52.
Zurück zum Zitat Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, Y. Shen, J. Du, Y.P. Rubtsov, A.Y. Rudensky, S.F. Ziegler, and D.R. Littman. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236–240.PubMedCentralPubMedCrossRef Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, Y. Shen, J. Du, Y.P. Rubtsov, A.Y. Rudensky, S.F. Ziegler, and D.R. Littman. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236–240.PubMedCentralPubMedCrossRef
53.
Zurück zum Zitat Schambach, F., M. Schupp, M.A. Lazar, and S.L. Reiner. 2007. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. European Journal of Immunology 37: 2396–2399.PubMedCrossRef Schambach, F., M. Schupp, M.A. Lazar, and S.L. Reiner. 2007. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. European Journal of Immunology 37: 2396–2399.PubMedCrossRef
54.
Zurück zum Zitat Spach, K.M., F.E. Nashold, B.N. Dittel, and C.E. Hayes. 2006. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. The Journal of Immunology 177: 6030–6037.PubMedCrossRef Spach, K.M., F.E. Nashold, B.N. Dittel, and C.E. Hayes. 2006. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. The Journal of Immunology 177: 6030–6037.PubMedCrossRef
Metadaten
Titel
Vitamin D Improves Cognitive Function and Modulates Th17/Treg Cell Balance After Hepatectomy in Mice
verfasst von
Ayong Tian
Hong Ma
Xuezhao Cao
Rongwei Zhang
Xiaolong Wang
Binyang Wu
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2015
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9956-4

Weitere Artikel der Ausgabe 2/2015

Inflammation 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.